Dr. William R. Jarvis
- Infectious Diseases, Infection Control, Epidemiology, Public Health, and Pediatrics




 CA, OR, and SC, USA       
Expertise Education Work History Career Accomplishments Sampling of Publications Government Experience Consulting Services International Experience Additional Experience Hobbies and Interests


Summary of Expertise:
-- Primary Expertise -- -- Description --
Bacillus Calmette-Guerin vaccine,
Mycobacterium tuberculosis,
tuberculosis
 
Dr. William R. Jarvis was an author on the Centers for Disease Control and Prevention (CDC) Guideline for Prevention of Transmission of M. tuberculosis in Healthcare Settings and the WHO Guideline for Prevention of M. tuberculosis Transmission in Healthcare Settings in Developing Countries. He was also involved in the conduct of studies of the efficacy of infection control measures in preventing hospital transmission of M. tuberculosis and of BCG vaccine in the prevention of TB and/or mycobacteremia in patients and/or healthcare workers in the United States, Thailand, Taiwan, Malawi, and other countries. In addition, he participated in a number of studies assessing the immunology of BCG vaccine and its ability to prevent TB.  Recently, he was a member of the CDC Division of TB Elimination's TBSC Working Group.
bacterial contamination
 
For 17 years, Dr. Jarvis coordinated and supervised the branch at the Centers for Disease Control and Prevention (CDC) that was responsible for conducting investigations of outbreaks in healthcare settings. He and his team investigated over 150 outbreaks, solved them all, and prevented recurrences. The investigations led to over 200 peer-reviewed publications. Many of these outbreaks involved intrinsic (at the time of manufacture) or extrinsic (at time of use) contamination with bacteria. In each outbreak, the source and mode of contamination was identified. Often, these investigations involved collaboration with manufacturers, the Food and Drug Administration, and local and state health departments. Dr. Jarvis is a world's expert on outbreak investigations in health care settings and frequently makes presentations on this subject.
clinical medicine
 
Dr. Jarvis is board certified in pediatrics and has training in pediatric infectious diseases, epidemiology, and public health and preventive medicine. He has attended in pediatric infectious diseases at Emory University for over 20 years. In addition, he frequently gives lectures, teaches courses, or mentors medical students, public health students or pediatric infectious disease fellows. He has written many peer review publications, book chapters, and surveillance reports on clinical medicine, particularly involving infectious diseases and healthcare-associated infections. Dr. Jarvis often lectures on clinical infectious diseases at national and international meetings. In addition, he has trained over 50 U.S. and over 20 international clinicians in healthcare epidemiology and infection prevention and control.
clinical research
clinical study
 
Dr. Jarvis has been involved in conducting clinical research for over 23 years. He has developed or supervised the development and conduct of nearly 100 study protocols, is familiar with ethical and human subjects issues, study design, data collection, data analysis and publication of data from studies. He has over 70 publications of clinical studies, most involving healthcare epidemiology, prevention and control of infections in hospitals, prevention of M. tuberculosis transmission in healthcare settings, and in enhancing clinical medicine and microbiology in developing countries. In addition, he has designed and conducted studies of detection of bloodstream infections in febrile patients in developing countries.
epidemiology
 
Dr. Jarvis was trained in epidemiology and public health at Yale University School of Medicine and in Preventive Medicine at the Centers for Disease Control and Prevention (CDC). He was an adjunct assistant professor at the Rollins School of Public Health at Emory University where he lectured on prevention and control of healthcare-associated infections for over 10 years. He held a number of positions at CDC, including Assistant Chief of the National Nosocomial Infections Surveillance (NNIS) system, and Chief of the Epidemiology Branch. For 17 years, he coordinated and supervised the Branch at the Centers for Disease Control and Prevention (CDC) that was responsible for conducting investigations of outbreaks in healthcare settings. He and his team investigated over 150 outbreaks, solved them all, and prevented recurrences. The investigations led to over 200 peer-reviewed publications. Many of these outbreaks involved intrinsic (at the time of manufacture) or extrinsic (at time of use) contamination with bacteria. In each outbreak, the source and mode of contamination was identified. Often, these investigations involved collaboration with manufacturers, the Food and Drug Administration and local and state health departments. He also was responsible for the development and publication of many of the Hospital Infection Program (now the Division of Healthcare Quality Promotion)/CDC Guidelines for the Prevention of Nosocomial Infections.  Dr. Jarvis currently is Chair of the FDA's General Hospital and Personal Use Devices Committee.
home health care
 
For 17 years, Dr. Jarvis coordinated and supervised the Branch at the Centers for Disease Control and Prevention (CDC) that was responsible for conducting investigations of outbreaks in healthcare settings. He and his team investigated over 150 outbreaks, solved them all, and prevented recurrences. The investigations led to over 200 peer-reviewed publications. His branch was the first to investigate outbreaks associated with provision of intravenous therapy in home settings. These led to a JAMA article on bloodstream infections in home care associated with needleless devices. In addition, he and his team investigated a number of other outbreaks in home health care settings and published these results. He has published on the importance of surveillance for infections associated with home health care. He has been a speaker on infections and infection prevention in home care at national and international meetings. He has worked with national organizations and local and state health departments to develop definitions of and methods for surveillance for infections in home care.
immunization
 
Dr. Jarvis is a board certified pediatrician with subsequent training in pediatric infectious diseases. He has been a reviewer and author of many of the chapters in the American Academy of Pediatrics (AAP) Red Book, a guide for clinicians on immunization practices. In addition, he has conducted and published several studies on immunization practices in patients and healthcare workers. He was the supervisor of the Hospital Infections Program, Centers for Disease Control and Prevention's Guideline for Prevention of Infection In Healthcare Workers. He has been a vocal advocate for immunization of pediatric patients and for healthcare workers to prevent the emergence of antimicrobial resistance. He is an author of the 12 steps program for prevention of antimicrobial resistance in pediatric patients, which highlights the importance of immunization.
antibacterial soap
 
Dr. Jarvis was a co-author of the CDC Hand Hygiene Guideline and has been involved in numerous studies evaluating the impact of antimicrobial soaps. In addition, he has conducted numerous outbreak investigations in which hand hygiene was a factor. He has consulted with several manufacturers who produce hand hygiene (antibacterial soaps) products. He has been active in recommending simple and effective measures to enhance hand hygiene in international healthcare settings.
infection control
 
Dr. Jarvis has been a leader in infection control for over 20 years. He has been President of The Society for Healthcare Epidemiologists of America (SHEA), Member and Chair of the  Association for Professionals in Infection Control, Inc. (APIC) Research Foundation, and is active in other SHEA and APIC activities. He has investigated and published over 150 hospital outbreaks, supervised and was an author on many of the current infection control guidelines, conducted hundreds of epidemiologic studies, and trained over 50 EIS officers at CDC. He spent over 22 years at CDC in leadership positions in infection control and is considered one of the world's experts in this area. He is the former Editor of the infection control journal, Infection Control and Hospital Epidemiology.  Dr. Jarvis currently is Chair of the FDA's General Hospital and Personal Use Devices Committee.  He has edited three books on healthcare epidemiology, including the book, Hospital Infections.
infection prevention
 
Dr. Jarvis has published a wide variety of infection prevention guidelines at CDC and with SHEA. He has conducted numerous intervention studies documenting prevention in action. He has over 350 publications on infection prevention. He is viewed as one of the world's experts in real infection prevention in the United States and throughout the world. He is working with a variety of medical manufacturers to implement infection prevention measures throughout the world. Dr. Jarvis has conducted studies to document the prevention and control of a wide variety of outbreaks and of methicillin-resistant Staphylococcus aureus (MRSA), M. tuberculosis, vancomycin-resistant enterococcus (VRE), and other antimicrobial-resistant pathogens.
infectious disease
 
Dr. Jarvis is trained in pediatric infectious diseases and has practiced for over 25 years. He was on the faculty at Emory University School of Medicine and has written widely on the subject. He has trained numerous infectious diseases fellows. He speaks widely on infectious disease treatment and prevention. He has over 600 infectious disease publications.
infectious disease control
 
Dr. Jarvis has been involved and a leader in infectious disease control for over 25 years. He has written widely, made presentations, and consulted on infectious disease control throughout the United States and the world. He has over 350 publications in the area and consults with medical device and product manufacturers on this subject.
medical device
 
Dr. Jarvis has wide experience with medical devices. While at CDC, he often supervised outbreak investigations involving such devices. He has worked with the FDA and State Health Departments on medical device evaluation. He has consulted with medical device manufacturers. He has been on national and international committees making recommendations on medical device use. He helped design the CDC's National Nosocomial Infections Surveillance (NNIS) system, which is the world's model for the surveillance of nosocomial infections and for the determination of device-related and surgical site infection rates. Dr. Jarvis is leading a national and international effort to reduce central venous catheter (CVC)-associated bloodstream infections (BSIs). Dr. Jarvis is an author on the inter-society guideline for the prevention of infections associated with gastrointestinal endoscopy.  Dr. Jarvis currently is Chair of the FDA's General Hospital and Personal Use Devices Committee..
medical instrument
 
Dr. Jarvis has been involved in the evaluation of medical instruments for over 30 years. He has written guidelines, and conducted outbreak investigations and epidemiologic studies evaluating such devices. He helped deisgn the CDC NNIS methodology for determining device-related infections.
nosocomial infection
 
Dr. Jarvis is a world leader in nosocomial infection control. He has been President of SHEA, and was on the SHEA annual meeting planning committee. He was Editor of ICHE (the SHEA journal). He has been involved in the prevention and control of nosocomial infections for over 30 years. Dr. Jarvis has written over 350 peer-reviewed publications on this subject, one book, and numerous guidelines and surveillance reports. He has consulted throughout the world on infection prevention. He is one of the world's leading experts in the area.
primary drug resistance
 
Dr. Jarvis has been a world's leader in studying the epidemiology and impact of antimicrobial resistance. He is a co-author of the SHEA Guideline to control antimicrobial resistance and has conducted numerous interventions showing how infection control methods (rather than antimicrobial controls) can reduce the transmission of MRSA, VRE and other multidrug-resistant pathogens.
Pseudomonas aeruginosa
 
Dr. Jarvis has conducted studies of, outbreak investigations of, and written about P. aeruginosa for 30 years. He has authored both chapters and guidelines on this subject. He has presented at national and international meetings on this subject.
Pseudomonas pickettii
 
Dr. Jarvis has conducted outbreak investigations of and written widely about this pathogen. He is viewed as one of the world's leading experts in the epidemiology of this pathogen in hospital infections.
public health
health care system
 
Dr. Jarvis spent 23 years in the U.S. Public Health Service (PHS), rising to the rank of Captain (retired). He was at CDC for these 23 years and is viewed as a world's expert in public health. He has interacted and collaborated with other PHS agencies, including the FDA and NIH, with the WHO, and with U.S. state health department personnel. He has collaborated with other PHS agencies on outbreak investigations, guideline development, and epidemiologic studies. He has a very solid understanding of how the public health system works in the United States and throughout the world.
staphylococcal infection
 
Dr. Jarvis is a world's expert in staphylococcal infections. He has conducted numerous studies, written guidelines, and investigated outbreaks involving these pathogens. He has conducted studies showing how to reduce infections by these pathogens. He has treated many children with staphylococcal infections. He was an author on the first description of a vancomycin intermediate-resistant Staphylococcus aureus (VISA) strain in the United States. He wrote the guideline for prevention of transmission of VISA and VRSA. He is an author of the SHEA Guideline for the control of MRSA, VRE, VISA and VRSA. He has conducted numerous studies documenting the efficacy of active surveillance cultures, contact precautions, and hand hygiene in the control of transmission of VRE in healthcare settings. He has consulted with medical manufacturers and with medico-legal experts on prevention and control of staphylococcal infections. He has been an advocate for the implementation of evidence-based Active Detection and Isolation (ADI) for the control of MRSA.
surgical infection
 
Dr. Jarvis is a world's expert in surgical infection epidemiology and prevention. He is a co-author on the CDC Guideline for Prevention of Surgical Site Infection (SSI). He was a member of the team which designed the CDC NNIS system surgical site surveillance program and surgical site risk index. He has conducted numerous studies of, and has made presentations throughout the world on, SSI prevention. Dr. Jarvis has consulted with medical manufacturers on SSI prevention. He has conducted numerous outbreak investigations and published on SSI prevention and risk factors.  He has experience investigating increased SSI rates in inpatient and outpatient settings.
vaccination
 
As a pediatric infectious disease expert, Dr. Jarvis is very familiar with vaccination strategies. He has conducted numerous studies of vaccine preventable diseases and the impact of vaccination on infectious diseases in international settings. He is an author of many chapters in the AAP Red Book, the national and internationalreference text for vaccination practices.
pediatrics
 
Dr. Jarvis is trained in pediatrics and pediatric infectious diseases. He has attended in pediatric infectious diseases at Emory University School of Medicine for over 20 years. He was on the faculty at Emory University School of Medicine Department of Pediatrics. He has conducted numerous outbreak investigations and studies in pediatric infectious diseases.  He designed and initiated the Pediatric Prevention Network while he was at the CDC.



Secondary Expertise

acquired immunodeficiency syndrome, acute wound, antibiotic, antimicrobial medical device, antiseptic material, artificial joint, bacitracin, bacterial disease, bacterial pneumonia, bacteriology, bacterium, biomedical device, biomedical diagnostic instrumentation, biomedical instrumentation, biomedicine, blood transfusion, burn surgery, bypass surgery, cannula, cardiovascular surgery, catheterization, chickenpox, clinical immunology, clinical laboratory, clinical protocol, clinical research management, clinical trial design, diagnostics, disease, disinfectant, disinfection, disposable medical device, endoscope, fungus disease, gastroenterology, geriatrics, germicide, governmental registration process, hip surgery, hospital equipment, hospital equipment safety, host resistance, humoral immunology, hygiene, immunology, implantable device, infection process, infectious cardiovascular disease, infectious digestive system disease, infectious disease diagnosis, infectious disease treatment, infectious gastrointestinal system disease, infectious lymphatic system disease, infectious mononucleosis, infectious musculoskeletal disease, infectious nervous system disease, infectious reproductive system disease, infectious respiratory system disease, infectious skin disease, infectious urinary system disease, legionellosis, medical waste disinfection, microbial control, minimally invasive surgery, neonatology, pertussis, plastic medical device, preventive medicine, skin blister prevention, spine surgery, staphylococcal enterotoxin, sterilant, streptococcal infection, streptomycin, surgery, surgical care, surgical instrument, surgical product, surgical staple, therapeutic device, toxic shock syndrome, tuberculous meningitis, viral disease, water disinfectant, water disinfection, wound healing



Basic Expertise
anesthesiology, angioplasty, angioplasty equipment, anthrax, antibody, antibody production, antimicrobial additive, antimicrobial coating, artificial cardiac pacemaker, artificial eye, artificial heart, artificial kidney, artificial liver, artificial organ, Band-Aid, bioabsorbable material, bio-clean room, biocompatible material, blood sampling, bone healing, botulism, brucellosis, cannulation, cardioplegia, catheter tubing, cellular immunology, cold gaseous sterilant, cold liquid sterilant, cytomegalic inclusion disease, disposable surgical product, electrocardiograph, electrocautery instrument, electroencephalograph, electronic medical device, electrosurgery, electrosurgical instrumentation, emergency medicine, eye surgery, fetal wound healing, gonorrhea, heart-lung machine, hip replacement, hysterectomy, laser surgery, leptospirosis, listeriosis, Lyme disease, mechanical organ, medical filter, medical inhaler, medical oxygen concentrator, microsurgery, molecular immunology, nephrology, neurology, neurosurgery, nocardiosis, oral surgery, orthopaedic surgery, otolaryngologic surgery, paratyphoid fever, plastic surgery, prosthesis, prosthetic material, rectal surgery, serology, skin substitute, stent, therapeutics, thoracic surgery, ureteroscopic device, urologic surgery



Education:
Year   Degree   Subject   Institution   Honors
1974   M.D.   Medicine   University of Texas, Houston  
1970   B.S.   Psychology   University of California, Davis   High Honors



Work History:
Years   Employer   Department   Title   Responsibilities
2003-current   Jason and Jarvis Associates  
  President   Dr. Jarvis is responsible for medical consulting in infectious diseases, pediatric infectious diseases, infection control, healthcare epidemiology, infection prevention, protocol design (research), survey design, epidemiology, study conduct, and public health.
2002 to 2003   Centers for Disease Control and Prevention   Office of Extramural Research, National Center for Infectious Diseases   Director
  Dr. Jarvis was responsible for starting and building the first office of extramural research in the CDC's National Center for Infectious Diseases and funded over $10 million in grants. He built the office of extramural research in NCID, CDC. He worked closely with the NIH's Office of Extramural Research.
1980 to 2002   Centers for Disease Control and Prevention   Hospital Infections Program
  Acting Director; Assoc. Director for Program Development; Chief, Investigation and Prevention Branch   For 17 years, he was responsible for the investigation (supervision) of all outbreaks and epidemiologic studies in healthcare settings and for developing all CDC guidelines for prevention of infection in healthcare settings. He was also responsible for training EIS officers in epidemiologic methods and outbreak investigation.
1985 to 2005   Emory University School of Medicine   Department of Pediatrics, Division of Pediatric Infectious Diseases, Epidemiology, and Immunology   Clinical Associate Professor   He was responsible for attending on pediatric infectious diseases, and teaching and mentoring Fellows in infectious diseases.
1990 to 2005   Emory University, Rollins School of Public Health   Department of Epidemiology   Clinical Assistant Professor   Dr. Jarvis was responsible for lecturing in healthcare epidemiology, outbreak investigation, and healthcare-associated infection prevention.



Career Accomplishments:
Associations/Societies
Dr. Jarvis is a member of SHEA, APIC, IDSA, and ASM.
 
Licenses/Certifications
He has an M.D. degree and holds medical licenses in Georgia, Texas, and California.
 
Professional Appointments
Dr. Jarvis was Editor of “Infection Control and Hospital Epidemiology,” former President of the Society of Healthcare Epidemiology of America, and foprmer President and Member of the APIC Research Foundation Board of Directors. 
Dr. Jarvis currently is Chair of the FDA's General Hospital and Personal Use Devices Committee.
 
Awards/Recognition
He is a Fellow of the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiologists of America (SHEA).  He graduated from college with High Honors. Dr. Jarvis is a two-time recipient of the Spark's award for academic excellence, has over 20 PHS awards, received the CDC Philip Brachman (teaching) Award, the CDC Lifetime Achievement Award (2003), the CDC Lifetime Achievement Award in Epidemiology (2010), the SHEA Lectureship, and APIC State of the Science Scientific Excellence awards.
 
Medical/Professional Internships
Dr. Jarvis was an intern in Pediatrics at the University of Texas, Houston.  He completed his Residency in Pediatrics at the Children's Hospital of Los Angeles. He had a Pediatric Infectious Disease Fellowship at the Hospital for Sick Children in Toronto, and at Yale University School of Medicine (virology and public health). He completed his Preventive Medicine Residency at CDC.
 
Publications and Patents
He has over 400 peer-reviewed publications, 50 book chapters, edited three books, and over 50 CDC surveillance reports (MMWRs). He also has much experience with the media (print and television).
 



Sampling of Publications:
Author   Year   Title   Publisher  
Muto, C.A., J.A. Jernigan, B.E. Ostrowsky, H.M. Richet, W.R. Jarvis, J.M. Boyce, and B.M. Farr   2003   SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus   Infection Control & Hospital Epidemiology. 24: 362-86  
Kainer, M.A., J.V. Linden, D.N. Whaley, H.T. Holmes, D.B.Jernigan, W.R. Jarvis, and L.K. Archibald   2004   Allograft-Associated Clostridium spp. Infections: The Need for Tissue Transplant Safety   New England Journal of Medicine. 350: 2564-2571  
Ostrowsky, BE, C Whitener, KH Brendenberg, LA Carson, S Holt, L Hutwagner, MJ Arduino, & WR Jarvis   2002   Serratia marcescens Bacteremia Traced to an Infused Narcotic   New England Journal of Medicine. 346: 1529-1537  
Grohskopf LA, VR Roth, DR Feikin, MJ Arduino, LA Carson, JI Tokars, SC Holt, RE Hoffman, & WR Jarvis   2001   Serratia liquefaciens Bloodstream Infections from Contamination of Epoetin Alfa at a Hemodialysis Center   New England Journal of Medicine. 344: 1491-1497  
Archibald LK, LC McDonald, O Nwanyanwu, P Kazembe, H Dobbie, J Tokars, B Reller, and WR Jarvis   2000   A Hospital-Based Prevalence Survey of Bloodstream Infections in Febrile Patients in Malawi: Implications for Diagnosis and Therapy   Journal of Infectious Diseases 181: 1414-1420  



Government Experience:
Years   Agency   Role   Description
1980 to 2003   Centers for Disease Control and Prevention   Acting Director, Hospital Infections Program; Director, Office of Extramual Research, NCID   Dr. Jarvis was Chief, Epidemiology Branch; Chief, Investigation and Prevention Branch; and Acting Director of the Hospital Infections Program. He supervised outbreak investigations, epidemiology training, and guideline development. He was Assistant Director for Program Development, Division of Healthcare Quality Promotion (formerly HIP).  He also began and developed the Office of Extramural Research in NCID, which funded over 10 million dollars in grants.



Consulting Services:
Dr. Jarvis supervised the conduct over 150 on-site outbreak investigations in the U.S. and throughout the world and solved them all.
 
He has consulted with medical manufacturers, hospitals, and Ministries of Health. He has also consulted in infection control and infectious diseases in numerous countries throughout the world and for the WHO and PAHO.
 
Dr. Jarvis was responsible for providing epidemiology training to over 100 physicians (Epidemic Intelligence Service [EIS] Officers while at CDC, during their two-year training periods.
 
He developed the CDC's National Nosocomial Infections Surveillance (NNIS) system.
 



International Experience:
Years   Country / Region   Summary
1995 to   Asia   Dr. Jarvis has consulted and conducted studies in China, Malaysia, Taiwan, Thailand, Indonesia, Vietnam, Australia, New Zealand, and other Asian countries.
1994 to   Africa   He has consulted on infectious diseases (including tuberculosis) and infection control in several countries in Africa (Malawi, Mozambique, Botswana, etc.)
1985 to   Indonesia   Dr. Jarvis consulted and helped the Indonesian government and Dr. Soetoma Hospital develop an infection control program.
1991 to   South America   He has consulted and conducted studies in a wide variety of South American countries and assisted them in developing infection control guidelines and surveillance systems (Brazil, Argentina, Chile, Colombia, Mexico).
1993 to   U.S., Canada, and Other Countries   Dr. Jarvis started the Pediatric Prevention Network in the U.S. and Canada (and a few other countries). This was the first pediatric multicenter collaborative effort to conduct surveillance and epidemiologic studies in infection control and prevention in pediatric patients in the United States and throughout the world.



Additional Experience:
Expert Witness
Dr. Jarvis provided medical-legal assistance to the Department of Justice and to a variety of private lawyers and hospitals.
 
Training/Seminars
He has provided symposia and presentations all over the world (over 1000 presentations at major meetings).
 
Other Relevant Experience
Dr. Jarvis has provided consultation to the pharmaceutical and medical manufacturing industry.
 



Hobbies and Interests:

Dr. Jarvis is interested in international travel, skiing, bike riding, tennis, stocks, and reading. 
He leads a bi-coastal life, spending Autumn through Spring on Hilton Head Island, South Carolina and Summers in Port Orford, Oregon and San Francisco, California.



Home Page | Contact | Areas of Expertise | Janine Jason, M.D. | William R. Jarvis, M.D. | Disclaimer |